-
Marcus Home Page
VISION: The vision of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) is to bring together bioengineers, manufacturing engineers, and industrial engineers to work closely with cell biologists, clinicians, and industry partners to make cell therapy manufacturing a well-characterized, quality-controlled, efficient, and highly-reproducible process for broad clinical use.
MISSION: The Marcus Center will become one of the world’s premier authority for cell characterization, manufacturing, and scale-up process development. The Center will be recognized AND utilized as THE NATIONAL RESOURCE for standardization of cell-production, characterization, and potency determination.
The initial focus of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) are in the areas of (a) mesenchymal stromal/stem cells (MSCs) from bone marrow and cord tissue for immune-modulation and tissue-biofabrication, (b) T and B cells for immunotherapies in cancer, infectious and autoimmune diseases; and (c) Cord blood and bone marrow hematopoietic stem cells for regenerative medicine. The Center will implement the National Roadmap for Cell Manufacturing, recently published by the National Cell Manufacturing Consortium and highlighted by the White House.
GOALS: The goals of the Marcus Center are to:
Uniqueness of the Marcus Center
Learn More
New Facilities and Interfacing with Existing Infrastructure
Learn More
Georgia Tech has already been chosen by the federal government to lead the nationwide consortium
Learn More
© 2016 Cell Manufacturing and Petit Institute of Bioengineering and Bioscience
Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech
315 Ferst Dr. NW, Atlanta, GA 30332-0363